Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score Analysis
Authors:
- Hirotsugu MaruyamaHMHirotsugu Maruyama
- Kojiro TanoueKTKojiro Tanoue
- Yuki Ishikawa-KakiyaYIYuki Ishikawa-Kakiya
- Masafumi YamamuraMYMasafumi Yamamura
- Akira HigashimoriAHAkira Higashimori
- Masaki OminamiMOMasaki Ominami
- Yuji NadataniYNYuji Nadatani
- Shusei FukunagaSFShusei Fukunaga
- Koji OtaniKOKoji Otani
- Shuhei HosomiSHShuhei Hosomi
- Fumio TanakaFTFumio Tanaka
- Noriko KamataNKNoriko Kamata
Open Access
- 21 February 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 554
Abstract
Background: Inflammation-based scoring has been reported to be useful for predicting the recurrence and prognosis of various carcinomas. This study retrospectively investigated the relationship between inflammation-based score and intraductal papillary mucinous neoplasms (IPMNs). Methods: Between January 2013 and October 2018, we enrolled 417 consecutive patients with pancreatic tumors who received surgical resections at our hospital. The main outcome was the association between the preoperative inflammation-based score and their accuracy in predicting malignant transformation of IPMN. Results: Seventy six patients were eligible. Pathological findings indicated that 35 patients had low-grade dysplasia, 18 had high-grade dysplasia, and 23 had invasive carcinomas. As the C-reactive protein albumin ratio (CAR) was higher, malignant transformation of IPMNs also increased (p = 0.007). In comparing CARhigh and CARlow using cutoff value, the results using a propensity score analysis showed that the CARhigh group predicted malignant transformation of IPMNs (odds ratio, 4.18; 95% confidence interval, 1.37–12.8; p = 0.01). In the CARhigh group, disease-free survival (DFS) was significantly shorter (p = 0.04). In the worrisome features, the AUC for the accuracy of malignant transformation with CARhigh was 0.84 when combining with the MPD findings. Conclusions: Preoperative CAR could be a predictive marker of malignant transformation of IPMNs.Keywords
This publication has 33 references indexed in Scilit:
- Role of the immune system in pancreatic cancer progression and immune modulating treatment strategiesCancer Treatment Reviews, 2014
- A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumoursSurgical Oncology, 2014
- The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2012
- Intraductal papillary mucinous neoplasms of the pancreas—a surgical diseaseNature Reviews Gastroenterology & Hepatology, 2012
- Comparison of the Prognostic Value of Tumour‐ and Patient‐Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal CancerWorld Journal of Surgery, 2011
- A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal AdenocarcinomaAnnals of Surgical Oncology, 2011
- Evaluation of Surgical Outcome Scores according to ISGPS Definitions in Patients Undergoing Pancreatic ResectionDigestive Surgery, 2010
- Treatment Guidelines for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: When Can We Operate or Observe?Annals of Surgical Oncology, 2007
- Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancerInternational Journal of Colorectal Disease, 2007
- Inflammation and cancerNature, 2002